Sordarin oxazepine derivatives as potent antifungal agents.
Michael H Serrano-Wu, Denis R St Laurent, Yijun Chen, Stella Huang, Kin-Ray Lam, James A Matson, Charles E Mazzucco, Terry M Stickle, Thomas P Tully, Henry S Wong, Dolatrai M Vyas, Balu N Balasubramanian
Author Information
Michael H Serrano-Wu: Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492, USA. michael.serrano-wu@bms.com
The synthesis and biological activity of sordarin oxazepine derivatives are described. The key step features a regioselective oxidation of an unprotected triol followed by double reductive amination to afford the ring-closed products. The spectrum of antifungal activity for these novel derivatives includes coverage of Candida albicans, Candida glabrata, and Cryptococcus neoformans.